HC Wainwright & Co. Maintains Buy on MiMedx Group, Lowers Price Target to $8
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains a Buy rating on MiMedx Group (NASDAQ:MDXG) but lowers the price target from $9.5 to $8.
June 21, 2023 | 10:13 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HC Wainwright & Co. maintains a Buy rating on MiMedx Group (NASDAQ:MDXG) but lowers the price target from $9.5 to $8.
The news of HC Wainwright & Co. maintaining a Buy rating on MiMedx Group (NASDAQ:MDXG) is positive for the stock. However, the lowering of the price target from $9.5 to $8 may create some uncertainty among investors. The overall impact on the stock price in the short term is expected to be neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100